文献速递骨软组织肉瘤与黑色素瘤

四肢高级别骨肉瘤的病理性骨折与预后:COSS 2847例分析

Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.
PubMed 文献 · J Clin Oncol · 2020-01-13

该研究回顾性分析COSS数据库中1980至2010年登记的2847例四肢原发中心性高级别骨肉瘤患者,旨在探究病理性骨折与预后的相关性。结果显示,病理性骨折在成人患者中与较差的总体生存独立相关,但在儿童患者中无显著预后影响。

要点

  • 病理性骨折在全部患者中占11.3%,与肿瘤部位、组织学亚型、相对肿瘤大小及原发转移相关。

核心结论

  • 在四肢高级别骨肉瘤中,病理性骨折的发生与成人患者较差的总体生存期望相关,但在儿童患者中未见此关联。

研究设计与样本

  • 回顾性分析COSS数据库2847例原发中心性四肢高级别骨肉瘤患者,治疗时间为1980至2010年,意图治疗包括术前术后化疗和手术。
  • 对全部患者及按成人/儿童(诊断时≤18岁)分层的患者进行单变量和多变量生存分析。

主要发现

  • 全部患者中11.3%存在病理性骨折;病理性骨折与肿瘤部位、组织学亚型、相对肿瘤大小和原发转移显著相关,与体重指数或局部手术缓解无关。
  • 儿童患者中,伴与不伴病理性骨折的总生存和无事件生存均无显著差异。

临床怎么用

  • 对于成人四肢高级别骨肉瘤患者,病理性骨折的出现提示总体生存预后较差,可作为风险分层参考。
  • 儿童患者中病理性骨折未显示独立预后价值,临床决策需结合其他因素。

局限性

  • 回顾性研究设计,可能存在选择偏倚和未控制混杂因素。
  • 原文未报告具体化疗方案、手术细节及随访完整性等限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The objective of this study was to investigate potential correlations between pathologic fractures (PFs) and prognosis of patients with primary central high-grade osteosarcoma of the extremities. METHODS: We retrospectively analyzed 2,847 patients registered in the Consecutive Cooperative Osteosarcoma Study Group database with primary central high-grade osteosarcoma of the extremities, treated between 1980 and 2010. Intended treatment included pre- and postoperative chemotherapy and surgery. Univariable and multivariable survival analyses were performed for all patients and then differentiated for adult and pediatric (≤ 18 years at time of diagnosis) patients. RESULTS: A total of 2,193 patients were ≤ 18 years of age; 11.3% of all patients had PFs. In the overall cohort, presence of PF correlated significantly with tumor site, histologic subtype, relative tumor size, and primary metastases, but not with body mass index or local surgical remission. In univariable analysis, 5-year overall survival (OAS) of patients with and without PF was 63% versus 71%, respectively (P = .007), and 5-year event-free survival (EFS) was 51% versus 58% (P = .026). In pediatric patients, OAS and EFS did not differ significantly between patients with and without PF. In adults, 5-year OAS in patients with and without PF was 46% versus 69% (P < .001), and 5-year EFS was 36% versus 56% (P < .001). In multivariable analysis, PF was not a statistically significant factor for OAS or EFS in the total cohort or in pediatric patients. In adult patients, PF remained an independent prognostic factor for OAS (P = .013; hazard ratio [HR], 1.893). It was not a significant prognostic factor for EFS (P = .263; HR, 1.312). CONCLUSION: In this largest study to date with extremity osteosarcomas, we observed the occurrence of PF to correlate with inferior OAS expectancies in adult but not in pediatric patients.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Kelley LM, Schlegel M, Hecker-Nolting S, et al. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. J Clin Oncol. 2020. PMID: 31928458. doi:10.1200/JCO.19.00827

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。